sub:provenance {
  sub:assertion dcterms:description "[Using an extended DotScan(�) CLL antibody microarray (Version 3; 182 CD antibodies), and with refined analysis of purified CD19 + B-cells, the following 27 CD antigens were differentially abundant for progressive CLL: CD11a, CD11b, CD11c, CD18, CD19, CD20 (two epitopes), CD21, CD22, CD23, CD24, CD25, CD38, CD40, CD43, CD45, CD45RA, CD52, CD69, CD81, CD84, CD98, CD102, CD148, CD180, CD196 and CD270.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ;
    
wi:evidence dgn-void:source_evidence_literature ;
    
sio:SIO_000772 miriam-pubmed:24289109 ;
    
prov:wasDerivedFrom dgn-void:BEFREE ;
    
prov:wasGeneratedBy eco:ECO_0000203 . 
  
dgn-void:BEFREE pav:importedOn "2017-02-19"^^
xsd:date . 
  
dgn-void:source_evidence_literature a eco:ECO_0000212 ;
    
rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en ;
    
rdfs:label "DisGeNET evidence - LITERATURE"@en . 
}